NVO - NOVO NORDISK A S

QQQ $ 463.74 $ 0.15 (0.03 %)

DIA $ 400.12 $ 2.30 (0.58 %)

SPY $ 543.85 $ 1.71 (0.32 %)

TLT $ 97.88 $ 0.61 (0.63 %)

GLD $ 226.19 $ -1.86 (-0.82 %)

Previous Close

$ 134.42

Open

Bid

$ 134.39 x 100

Ask

$ 134.43 x 100

Day's Range

-- - --

52 Week Range

$ 86.34 - $ 148.15

Volume

1,967,949

Average Volume

Market Cap

606,234

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

$ 0.00

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

dont-promote-copycat-weight-loss-drugs-amid-improved-supply-eli-lilly-asks-doctors-fda-evaluates

Don't Promote Copycat Weight-Loss Drugs Am...
08/14/2024 18:35:14

Eli Lilly issues cease-and-desist letters to healthcare providers, demanding they stop promoting compounded weight-loss drugs a...

eli-lilly-smashed-estimates-thanks-to-unbelievable-demand-for-its-diabetes-and-weight-loss-blockbusters

Eli Lilly Smashed Estimates Thanks To Unbe...
08/14/2024 14:26:17

On Thursday, Eli Lilly and Company (NYSE: LLY) reported its second quarter results, smashing estimates fueled by the popularity...

weight-loss-drugs-like-ozempic-zepbound-may-reduce-cancer-risks-studies-suggest

Weight Loss Drugs Like Ozempic, Zepbound M...
08/12/2024 17:37:30

GLP-1 agonists like Ozempic and Wegovy, known for treating obesity and diabetes, are now showing potential in reducing cancer r...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

eli-lillys-q2-sales-surge-36-analysts-cautious-on-future-supply-market-dynamics-optimistic-about-next-gen-oral-weight-loss-drug

Eli Lilly's Q2 Sales Surge 36%, Analysts C...
08/09/2024 20:03:04

Eli Lilly's Q2 revenue soared to $11.3 billion, surpassing forecasts. Mounjaro sales tripled and Zepbound revenue grew sign...

BMO Capital Maintains Outperform on Novo N...
08/08/2024 15:52:44

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:NVO) with a Outperform and lowers the price target fro...

Lilly Executive Says Concord Manufacturing...
08/08/2024 14:52:15

Conference Call

novo-nordisk-withdraws-wegovy-fda-heart-failure-submission-terminates-development-of-two-early-stage-assets

Novo Nordisk Withdraws Wegovy FDA Heart Fa...
08/07/2024 17:55:16

Novo Nordisk missed Q2 earnings estimates and announced plans to resubmit Wegovy STEP HFpEF trial results for FDA review in ear...

wall-street-poised-for-second-day-of-gains-while-bank-of-japan-makes-reassurances-dollar-strengthens-against-yen-crude-prices-surge-whats-driving-markets-wednesday

Wall Street Poised For Second Day Of Gains...
08/07/2024 16:46:55

The U.S.

whats-going-on-with-eli-lilly-and-company-shares-wednesday

What's Going On With Eli Lilly And Company...
08/07/2024 16:22:44

Eli Lilly is anticipated to release earnings 2024 fiscal year earnings on Thursday before the market opens.

weight-loss-giant-novo-nordisk-tumbles-to-200-day-average-support-weakness-could-be-buying-opportunity-analyst-says

Weight-Loss Giant Novo Nordisk Tumbles To ...
08/07/2024 15:59:06

Shares of Novo Nordisk are down 6% after Q2 results fell short of expectations; weight-loss drug sales disappoint.

ozempic-maker-novo-nordisk-reveals-patients-stay-on-wegovy-weight-loss-drug-for-6-months-due-to-low-availability

Ozempic-Maker Novo Nordisk Reveals Patient...
08/07/2024 13:37:09

Novo Nordisk CFO Said In Active Dialogue W...
08/07/2024 11:41:07

novo-nordisk-tumbles-3-in-wednesday-premarket-whats-causing-miracle-weight-loss-drug-ozempic-makers-stock-slide

Novo Nordisk Tumbles 3% In Wednesday Prema...
08/07/2024 10:26:46

The dip in Novo Nordisk's shares comes despite deep-pocketed investors were adopting a bullish approach.

Novo Nordisk 2024 Outlook: Now Expects Sal...
08/07/2024 06:51:28

Sales growth is now expected to be 22% to 28% at CER. Given the current exchange rates versus the Danish krone, sales growth re...

Novo Nordisk Q2 2024 GAAP EPS DKK 4.49 Mis...
08/07/2024 06:45:27

Novo Nordisk (NYSE:NVO) reported quarterly earnings of $4.49 per share which missed the analyst consensus estimate of $5.05 by ...

novo-nordisk-unusual-options-activity-for-august-06

Novo Nordisk Unusual Options Activity For ...
08/06/2024 15:16:59

Cantor Fitzgerald Reiterates Overweight on...
08/05/2024 18:04:29

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:NVO) with a Overweight and maintains $160 price target.

eli-lillys-zepbound-challenges-novo-nordisks-wegovy-amid-supply-issues

Eli Lilly's Zepbound Challenges Novo Nordi...
08/05/2024 15:59:28

Eli Lilly's Zepbound and Novo Nordisk's Wegovy face supply shortages, influencing doctors' prescribing habits. Both...

after-ozempic-and-botox-hollywood-is-going-gaga-over-this-new-anti-aging-supplement

After Ozempic And Botox, Hollywood Is Goin...
08/05/2024 14:43:09

This trend is gaining momentum although its effectiveness is yet to be determined.